The binding orientation of a norindenoisoquinoline in the topoisomerase I-DNA cleavage complex is primarily governed by π-π stacking interactions

被引:21
|
作者
Song, Yunlong
Cushman, Mark [1 ]
机构
[1] Purdue Univ, Dept Med Chem & Mol Pharmacol, Sch Pharm & Pharmaceut Sci, W Lafayette, IN 47907 USA
来源
JOURNAL OF PHYSICAL CHEMISTRY B | 2008年 / 112卷 / 31期
关键词
D O I
10.1021/jp8005603
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
High level ab initio quantum chemical studies have shown that the binding orientations of topoisomerase I (top1) inhibitors such as camptothecins and indenoisoquinolines are primarily governed by pi-pi stacking. However, a recently discovered norindenoisoquinoline antitumor compound was observed by X-ray crystallography to adopt a "flipped" orientation (relative to indenoisoquinolines), which facilitates the formation of a characteristic hydrogen bond with the Arg364 of top1 in its binding with the top I-DNA complex. This observation raises the possibility that hydrogen bonding between the norindenoisoquinoline nitrogen and the Arg364 side chain of top1 might be responsible for the "flip". It also brings into question whether pi-pi, stacking, as opposed to hydrogen bonding, is primarily responsible for the binding orientations of indenoisoquinolines and norindenoisoquinolines. In this study, the forces responsible for the binding orientation of a norindenoisoquinoline in the DNA cleavage site were systematically investigated using MP2 methods. The theoretical calculation of the preferred binding orientation based solely on pi-pi stacking was completely consistent with the actual orientation observed by X-ray crystallography, indicating that the binding of the norindenoisoquinoline in the top1-DNA complex is mainly governed by pi-pi stacking forces and that the "flip" can occur independently from hydrogen bonding.
引用
收藏
页码:9484 / 9489
页数:6
相关论文
共 50 条
  • [1] A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex
    Marchand, C
    Antony, S
    Kohn, KW
    Cushman, M
    Ioanoviciu, A
    Staker, BL
    Burgin, AB
    Stewart, L
    Pommier, Y
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (02) : 287 - 295
  • [2] A molecular model for binding of camptothecin and its analogs in the topoisomerase I-DNA cleavable complex
    Fan, F
    Pommier, Y
    Kohn, KW
    Weinstein, JN
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 203 - MEDI
  • [3] Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
    Chan, Agnes L. -F.
    Chang, Wen-Shin
    Chen, Li-Min
    Lee, Chi-Ming
    Chen, Chiao-En
    Lin, Chun-Mao
    Hwang, Jau-Lang
    MOLECULES, 2009, 14 (04) : 1342 - 1352
  • [4] Glutathione conjugate of camptothecin is cytotoxic and enhances the stability of the topoisomerase I-DNA cleavage complex.
    Gamcsik, MP
    Colvin, OM
    Kohlhagen, G
    Urasaki, Y
    Kasibhatia, MS
    Adams, DJ
    Flowers, JL
    Pommier, Y
    Manikumar, G
    Wani, MC
    Wall, ME
    CLINICAL CANCER RESEARCH, 2000, 6 : 4511S - 4511S
  • [5] Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex
    Wang, XY
    Zhou, XA
    Hecht, SM
    BIOCHEMISTRY, 1999, 38 (14) : 4374 - 4381
  • [7] INTERACTION OF AN ALKYLATING CAMPTOTHECIN DERIVATIVE WITH A DNA-BASE AT TOPOISOMERASE I-DNA CLEAVAGE SITES
    POMMIER, Y
    KOHLHAGEN, G
    KOHN, KW
    LETEURTRE, F
    WANI, MC
    WALL, ME
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) : 8861 - 8865
  • [8] On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex
    Rahier, NJ
    Eisenhauer, BM
    Gao, R
    Thomas, SJ
    Hecht, SM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) : 1381 - 1386
  • [9] Cullin 3 promotes proteasomal degradation of the topoisomerase I-DNA covalent complex
    Zhang, HF
    Tomida, A
    Koshimizu, R
    Ogiso, Y
    Lei, SH
    Tsuruo, T
    CANCER RESEARCH, 2004, 64 (03) : 1114 - 1121
  • [10] Alteration of DNA primary structure by DNA topoisomerase I. Isolation of the covalent topoisomerase I-DNA binary complex in enzymatically competent form
    Henningfeld, KA
    Arslan, T
    Hecht, SM
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (47) : 11701 - 11714